AIP
TNXP icon

Ameritas Investment Partners’s Tonix Pharmaceuticals TNXP Stock Holding History

Ameritas Investment Partners’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6K Hold
773
– – ﹤0.01% 2846
2025
Q4 		$12.1K Hold
773
– – ﹤0.01% 2853
2025
Q3 		$18.7K Hold
773
– – ﹤0.01% 2689
2025
Q2 		$27.8K Buy
+773
New +$20.3K ﹤0.01% 2511
2022
Q2 		– Hold
0
– -$6K – 3231
2022
Q1 		– Hold
0
– – – 2941
2021
Q4 		– Hold
0
– – – 2932
2021
Q3 		– Hold
0
– – – 2826
2021
Q2 		– Hold
0
– – – 2557

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ameritas Investment Partners's TNXP Position: Q1 2026 in Review

Ameritas Investment Partners held its Tonix Pharmaceuticals (TNXP) position steady in Q1 2026 at 773 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

Ameritas Investment Partners first reported a position in TNXP in Q2 2025 and has held it in 4 quarters since. The position peaked at $27.8K in Q2 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Ameritas Investment Partners held 773 shares of Tonix Pharmaceuticals worth $10.6K as of Q1 2026.
  • Ameritas Investment Partners left its Tonix Pharmaceuticals share count unchanged in Q1 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2846 holding.
  • Ameritas Investment Partners first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Ameritas Investment Partners's Tonix Pharmaceuticals position peaked at $27.8K in Q2 2025.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.